Your browser doesn't support javascript.
loading
Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
Bitzenhofer, Michaela; Suter-Riniker, Franziska; Moor, Matthias B; Sidler, Daniel; Horn, Michael P; Gschwend, Anna; Staehelin, Cornelia; Rauch, Andri; Helbling, Arthur; Jörg, Lukas.
Affiliation
  • Bitzenhofer M; Division of Allergology and clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Suter-Riniker F; Clinical Microbiology, Institute for Infectious Disease, University of Bern, Bern, Switzerland.
  • Moor MB; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Sidler D; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Horn MP; Department of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Gschwend A; Division of Allergology and clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Staehelin C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Rauch A; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Helbling A; Division of Allergology and clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Jörg L; Division of Allergology and clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
PLoS One ; 17(6): e0268780, 2022.
Article de En | MEDLINE | ID: mdl-35679232

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / COVID-19 Type d'étude: Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / COVID-19 Type d'étude: Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique